Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapy

被引：11
作者：
Ashrani, A. A.
Gabriel, D. A.
Gajewski, J. L.
Jacobs, D. R., Jr.
Weisdorf, D. J.
Key, N. S.
机构：
[1] Univ Minnesota, Dept Med, Minneapolis, MN USA
[2] Univ N Carolina, Dept Med, Chapel Hill, NC USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Med, Houston, TX 77030 USA
[4] Univ Minnesota, Dept Epidemiol, Minneapolis, MN USA
来源：
BONE MARROW TRANSPLANTATION | 2006年 / 38卷 / 12期
关键词：
D O I：
10.1038/sj.bmt.1705535
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：825 / 828
页数：4
相关论文
共 9 条
  • [1] Off-label use of recombinant factor VIIa in patients following bone marrow transplantation
    Blatt, J
    Gold, SH
    Wiley, JM
    Monahan, PE
    Cooper, HC
    Harvey, D
    [J]. BONE MARROW TRANSPLANTATION, 2001, 28 (04) : 405 - 407
  • [2] INSOLUBLE FIBRIN CLOTS WITHIN URINARY-TRACT AS A CONSEQUENCE OF EPSILON AMINOCAPROIC ACID THERAPY
    COGGINS, JT
    ALLEN, TD
    [J]. JOURNAL OF UROLOGY, 1972, 107 (04) : 647 - &
  • [3] Successful treatment of cyclophosphamide induced intractable hemorrhagic cystitis with recombinant FVIIa (NovoSeven®) after allogenic bone marrow transplantation
    Karimi, M
    Zakerinia, M
    Khojasteh, HN
    Ramzi, M
    Ahmad, E
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (10) : 1853 - 1855
  • [4] Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease
    Key, NS
    Slungaard, A
    Dandelet, L
    Nelson, SC
    Moertel, C
    Styles, LA
    Kuypers, FA
    Bach, RR
    [J]. BLOOD, 1998, 91 (11) : 4216 - 4223
  • [5] Recombinant activated factor VII in treatment of bleeding complications following hematopoietic stem cell transplantation
    Pihusch, M
    Bacigalupo, A
    Szer, J
    Prondzinski, MV
    Gaspar-Blaudschun, B
    Hyveled, L
    Brenner, B
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (09) : 1935 - 1944
  • [6] The use of recombinant factor VIIa in the treatment of bleeding disorders
    Roberts, HR
    Monroe, DM
    White, GC
    [J]. BLOOD, 2004, 104 (13) : 3858 - 3864
  • [7] Risk factors for severe hemorrhagic cystitis following BMT
    Seber, A
    Shu, XO
    Defor, T
    Sencer, S
    Ramsay, N
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 (01) : 35 - 40
  • [8] West NJ, 1997, PHARMACOTHERAPY, V17, P696
  • [9] WILLIAMS JRB, 1951, BRIT J EXP PATHOL, V32, P530
1